Dr. Reddy's Laboratories Ltd. ADR buy HSBC Holdings plc
Start price
05.06.25
/
50%
€13.80
Target price
05.06.26
€14.80
Performance (%)
-18.12%
Price
08:16
?
Summary
This prediction is currently active. The price of Dr. Reddy's Laboratories Ltd. ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.12%. This prediction currently runs until 05.06.26. The prediction end date can be changed by HSBC_Holdings_plc at any time. HSBC_Holdings_plc has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | 0.000% | 0.000% |
| iShares Core DAX® | 0,42 % | 5,71 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % |
| iShares S&P 500 | 1,79 % | 9,64 % |
Comments by HSBC_Holdings_plc for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $16.90 price target on the stock, up previously from $14.44.
Ratings data for RDY provided by MarketBeat